Filing Details
- Accession Number:
- 0000784199-17-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-17 16:17:14
- Reporting Period:
- 2017-11-16
- Accepted Time:
- 2017-11-17 16:17:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1539068 | C David Gale | Cryolife, Inc. 1655 Roberts Blvd, N.w. Kennesaw GA 30144 | Vp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-16 | 10,000 | $5.76 | 87,135 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-16 | 10,000 | $19.63 | 77,135 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-16 | 10,000 | $6.12 | 87,135 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-16 | 10,000 | $19.63 | 77,135 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2017-11-16 | 10,000 | $0.00 | 10,000 | $5.76 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2017-11-16 | 10,000 | $0.00 | 10,000 | $6.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-02-18 | 2019-02-18 | No | 4 | M | Direct |
0 | 2014-02-15 | 2020-02-15 | No | 4 | M | Direct |
Footnotes
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013
- Reflects weighted average price. Range was $19.625 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/15/2014